Unlikely to cause harm — often a labeling or packaging issue.
Failed Dissolution Specifications: Product did not meet dissolution specification at an intermediate time point.
| Brand name | BUPROPION |
| Generic name | BUPROPION |
| Active ingredient(s) | BUPROPION HYDROCHLORIDE |
| Distributed by / for | Zydus Pharmaceuticals USA inc. Pennington, NJ 08534 |
| NDC | 68382-354-05 |
| Full product label | BuPROPion Hydrochloride Extended-Release Tablets, USP (XL) 300 mg, Rx Only, 500-count bottles, Manufactured by Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA inc. Pennington, NJ 08534, NDC 68382-354-05 |
| Recalling firm | Zydus Pharmaceuticals USA Inc |
| Distribution | Nationwide |
| Quantity | 2,472 units |
| Recall initiated | 2016-08-03 |
| Report date | 2016-11-30 |
| Recall completed | 2018-07-12 |
| Recall number | D-0149-2017 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | Pennington NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗